FDA’s pediatric adcomm votes to continue surveillance of 21 drugs, three vaccines
The FDA’s pediatric advisory committee voted almost unanimously to continue monitoring 21 drugs and three vaccines for side effects, including blockbusters such as Novartis’ heart …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
